INFORMATION TO BE INCLUDED IN STATEMENTS FILED

Company

RELMADA THERAPEUTICS, INC.

Filed

November 23, 2016

Accession Number

0001213900-16-018907

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →